Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
rituximab (rituxan) (1 trial)
Azotemia (Phase 2)
Hemolysis (Phase 2)
Hemolytic-Uremic Syndrome (Phase 2)
Purpura (Phase 2)
Purpura, Thrombocytopenic (Phase 2)
Purpura, Thrombotic Thrombocytopenic (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (1 total)